-
CME/CE
Updated ACCP Clinical Practice Guidelines on Medical Therapy for Pulmonary Arterial Hypertension
Drs. Nathan, Frost, and McLaughlin discuss the 2006 ACCP clinical practice guidelines on medical therapy for PAH and beyond, including new therapies on the market since their release.
Roundtable, June 2008
-
Postransplant Diabetes Mellitus After Pancreas Transplantation
This study is one of the largest and most analytical studies of postransplant diabetes mellitus in pancreas transplant recipients performed to date in the tacrolimus era.
Commentary, June 2008
-
Transplantation Criteria for Patients With Severe Pulmonary Hypertension and Grossly Impaired Right, but Relatively Normal Left Ventricular Function
Does any degree of right ventricular dysfunction warrant a heart-lung transplant over a lung transplant?
Ask the Expert, May 2008
-
Vitamin D and the Diabetic Patient
Daniel W. Coyne, MD, Professor of Medicine at Washington University, describes the consequences of low vitamin D and the potential to increase the risk for diabetes mellitus.
Expert Column, April 2008
-
Post-transplant Diabetes Mellitus and Acute Rejection: Impact on Kidney Transplant Outcome
The paradigm has shifted from an emphasis on short-term immunologic to long-term nonimmunologic outcomes as the ultimate measure of success in kidney transplantation.
Commentary, March 2008
-
Donor Biopsy and Kidney Transplant Outcomes: An Analysis Using the Organ Procurement and Transplantation Network/UNOS Database
When biopsy findings are unexpected or incongruent with the clinical picture, it may be difficult to reconcile the factors most important in determining kidney utilization.
Commentary, February 2008
-
Survival on Dialysis Post Kidney Transplant Failure: Results From the Scientific Registry of Transplant Recipients
The current study underscores the importance of managing graft failure, which could be avoided with preemptive retransplantation.
Commentary, January 2008
-
CME/CE
HPV Vaccines: Beyond Expectations
Emerging data show that HPV vaccines, which are close to 100% effective for preventing cervical cancer, may be efficacious in preventing other disease as well.
Roundtable, December 2007
-
CME
AASLD 2007: The Future of Hepatitis C Therapeutics
Tune in to this roundtable discussion, based on data from AASLD 2007, to hear Drs. Flamm, Zein, and Tran discuss the role of small-molecule therapies currently under investigation for hepatitis C.
Roundtable, December 2007
-
Individualized Mycophenolate Mofetil Dosing Based On Drug Exposure Significantly Improves Patient Outcomes After Renal Transplantation
If we are to believe the conclusions from this study, it is time to abandon fixed-dose MMF and utilize therapeutic drug monitoring to ensure optimal dosing.
Commentary, November 2007
